Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyCellularComponentcilium

GPI EVC2 FBXL13 DNAH10 CILK1 DNAAF11 PPEF2 APP ADGB GRK2 GRK3 WDR11 TTLL6 RP1 TSSK1B USH2A DNAH6

2.82e-0589812617GO:0005929
GeneOntologyCellularComponentcyclin A2-CDK1 complex

CCNA2 CDK1

3.60e-0521262GO:0097122
DomainTransferrin

TF MELTF

1.31e-0431242PF00405
DomainTransferrin

TF MELTF

1.31e-0431242IPR016357
DomainTRANSFERRIN_LIKE_4

TF MELTF

1.31e-0431242PS51408
DomainTRANSFERRIN_LIKE_1

TF MELTF

1.31e-0431242PS00205
DomainTRANSFERRIN_LIKE_2

TF MELTF

1.31e-0431242PS00206
DomainTRANSFERRIN_LIKE_3

TF MELTF

1.31e-0431242PS00207
DomainTransferrin_Fe_BS

TF MELTF

1.31e-0431242IPR018195
DomainTR_FER

TF MELTF

1.31e-0431242SM00094
DomainTransferrin-like_dom

TF MELTF

1.31e-0431242IPR001156
DomainSyja_N

INPP5F SYNJ2

4.32e-0451242PF02383
DomainSAC

INPP5F SYNJ2

4.32e-0451242PS50275
DomainSAC_dom

INPP5F SYNJ2

4.32e-0451242IPR002013
Pubmed

Phosphorylation of human Fen1 by cyclin-dependent kinase modulates its role in replication fork regulation.

CCNA2 FEN1 CDK1

4.62e-075126312853968
Pubmed

Enhanced contractility and decreased beta-adrenergic receptor kinase-1 in mice lacking endogenous norepinephrine and epinephrine.

DBH GRK2 GRK3

4.62e-075126310338466
Pubmed

beta2-Adrenergic receptor regulation by GIT1, a G protein-coupled receptor kinase-associated ADP ribosylation factor GTPase-activating protein.

GIT1 GRK2 GRK3

9.21e-07612639826657
Pubmed

The human cytoplasmic dynein interactome reveals novel activators of motility.

ACACB LIMD1 GIT1 DHX37 TBC1D5 ANKRD26 CILK1 DBT GRK2 WDR11 SYNJ2 EIF4G2 XRN1 VCPIP1

2.79e-068531261428718761
Pubmed

Cyclin A-Cdk1 regulates the origin firing program in mammalian cells.

CCNA2 CDK1

1.30e-052126219221029
Pubmed

Mitotic regulation of SIRT2 by cyclin-dependent kinase 1-dependent phosphorylation.

SIRT2 CDK1

1.30e-052126217488717
Pubmed

Expression patterns in mouse embryos of neuroleukin/glucose-6-phosphate isomerase and autocrine motility factor receptor.

GPI AMFR

1.30e-052126218537943
Pubmed

RNA-binding Protein Quaking Stabilizes Sirt2 mRNA during Oligodendroglial Differentiation.

SIRT2 QKI

1.30e-052126228188285
Pubmed

Identification of predicted human outer dynein arm genes: candidates for primary ciliary dyskinesia genes.

DNAH10 DNAH6

1.30e-052126215937072
Pubmed

The autocrine motility factor (AMF) and AMF-receptor combination needs sugar chain recognition ability and interaction using the C-terminal region of AMF.

GPI AMFR

1.30e-052126216563432
Pubmed

Purification of human tumor cell autocrine motility factor and molecular cloning of its receptor.

GPI AMFR

1.30e-05212621649192
Pubmed

The expression of zinc finger 804a (ZNF804a) and cyclin-dependent kinase 1 (CDK1) genes is related to the pathogenesis of rheumatoid arthritis.

ZNF804A CDK1

1.30e-052126231994908
Pubmed

Altered airway and cardiac responses in mice lacking G protein-coupled receptor kinase 3.

GRK2 GRK3

1.30e-052126210198406
Pubmed

G-protein coupled receptor kinase 2 and 3 expression in human detrusor cultured smooth muscle cells.

GRK2 GRK3

1.30e-052126211762794
Pubmed

The QKI-PLP pathway controls SIRT2 abundance in CNS myelin.

SIRT2 QKI

1.30e-052126221948283
Pubmed

AMF/G6PI induces differentiation of leukemic cells via an unknown receptor that differs from gp78.

GPI AMFR

1.30e-052126217071500
Pubmed

Upregulation of Cdc2 and cyclin A during apoptosis of endothelial cells induced by cleaved high-molecular-weight kininogen.

CCNA2 CDK1

1.30e-052126212742823
Pubmed

G protein-coupled receptor kinase 2 positively regulates epithelial cell migration.

GIT1 GRK2

1.30e-052126218369319
Pubmed

Cloning of GRK2 cDNA from S49 murine lymphoma cells.

GRK2 GRK3

1.30e-05212628638670
Pubmed

Dissecting the roles of GRK2 and GRK3 in μ-opioid receptor internalization and β-arrestin2 recruitment using CRISPR/Cas9-edited HEK293 cells.

GRK2 GRK3

1.30e-052126233060647
Pubmed

G protein--coupled receptor kinases.

GRK2 GRK3

1.30e-05212628035170
Pubmed

Sequences within the conserved cyclin box of human cyclin A are sufficient for binding to and activation of cdc2 kinase.

CCNA2 CDK1

1.30e-05212628423786
Pubmed

Expression patterns and prognostic values of the cyclin-dependent kinase 1 and cyclin A2 gene cluster in pancreatic adenocarcinoma.

CCNA2 CDK1

1.30e-052126233290118
Pubmed

CDK1 and CCNA2 play important roles in oral squamous cell carcinoma.

CCNA2 CDK1

1.30e-052126238640322
Pubmed

The Interleukin-2-mTORc1 Kinase Axis Defines the Signaling, Differentiation, and Metabolism of T Helper 1 and Follicular B Helper T Cells.

APP CCNA2 CXCR5 ARHGEF39 PLEKHG3 XRN1 CDK1

2.01e-05227126726410627
Pubmed

Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.

GPI NAA15 POLR1A DHX37 URB1 SF3B1 WDR11 PLEKHG3 FEN1 EIF4G2 XRN1 ANKIB1 PKP1 CPSF1 AP1G2 CDK1

3.21e-0513531261629467282
Pubmed

Loss of hepatocyte cell division leads to liver inflammation and fibrosis.

CCNA2 CDK1 ADGRE1

3.64e-0518126333147210
Pubmed

Human NK cells express CC chemokine receptors 4 and 8 and respond to thymus and activation-regulated chemokine, macrophage-derived chemokine, and I-309.

GRK2 GRK3

3.90e-053126210754297
Pubmed

Novel risk genes for systemic lupus erythematosus predicted by random forest classification.

ZNF804A CDK1

3.90e-053126228740209
Pubmed

Phosphorylation of human phospholipase A1 DDHD1 at newly identified phosphosites affects its subcellular localization.

CCNA2 CDK1

3.90e-053126234089703
Pubmed

A candidate syntenic genetic locus is associated with voluntary exercise levels in mice and humans.

MC3R GRM8

3.90e-053126224821406
Pubmed

MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer's disease.

RAG2 APP

3.90e-053126237708272
Pubmed

The CHFR mitotic checkpoint protein delays cell cycle progression by excluding Cyclin B1 from the nucleus.

CCNA2 CDK1

3.90e-053126215674323
Pubmed

Expression and prognostic value of CDK1, CCNA2, and CCNB1 gene clusters in human breast cancer.

CCNA2 CDK1

3.90e-053126233896262
Pubmed

Mutational and expression analysis of CDK1, cyclinA2 and cyclinB1 in epilepsy-associated glioneuronal lesions.

CCNA2 CDK1

3.90e-053126217359356
Pubmed

New alternative phosphorylation sites on the cyclin dependent kinase 1/cyclin a complex in p53-deficient human cells treated with etoposide: possible association with etoposide-induced apoptosis.

CCNA2 CDK1

3.90e-053126217636382
Pubmed

Differential effects of CC chemokines on CC chemokine receptor 5 (CCR5) phosphorylation and identification of phosphorylation sites on the CCR5 carboxyl terminus.

GRK2 GRK3

3.90e-053126210085131
Pubmed

Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor.

GRK2 GRK3

3.90e-05312627761854
Pubmed

The N-termini of GRK2 and GRK3 simulate the stimulating effects of RKIP on β-adrenoceptors.

GRK2 GRK3

3.90e-053126231604529
Pubmed

Cyclin A is required at two points in the human cell cycle.

CCNA2 CDK1

3.90e-05312621312467
Pubmed

Orphanin FQ/nociceptin-mediated desensitization of opioid receptor-like 1 receptor and mu opioid receptors involves protein kinase C: a molecular mechanism for heterologous cross-talk.

GRK2 GRK3

3.90e-053126212130708
Pubmed

QKI shuttles internal m7G-modified transcripts into stress granules and modulates mRNA metabolism.

METTL1 QKI

3.90e-053126237379838
Pubmed

On the concentrations of cyclins and cyclin-dependent kinases in extracts of cultured human cells.

CCNA2 CDK1

3.90e-053126210924145
Pubmed

DAP5 promotes cap-independent translation of Bcl-2 and CDK1 to facilitate cell survival during mitosis.

EIF4G2 CDK1

3.90e-053126218450493
Pubmed

A Cyclin-Binding Motif in Human SAMHD1 Is Required for Its HIV-1 Restriction, dNTPase Activity, Tetramer Formation, and Efficient Phosphorylation.

CCNA2 CDK1

3.90e-053126229321329
Pubmed

Inhibition of human cytomegalovirus immediate-early gene expression by cyclin A2-dependent kinase activity.

CCNA2 CDK1

3.90e-053126222718829
Pubmed

LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.

EPHB4 AMFR NAA15 POLR1A APP TMEM127 RNF43 COG8 URB1 FEN1 EIF4G2 QKI VCPIP1

3.96e-059421261331073040
Pubmed

Association study of 182 candidate genes in anorexia nervosa.

ACACB MC3R DBH GRK2 GRK3 GABRA5

5.54e-05182126620468064
Pubmed

A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.

POLR1A LIMD1 GIT1 DHX37 ANKRD26 SMG5 URB1 GRK2 SYNJ2 TADA2B XRN1

6.87e-057241261136232890
Pubmed

Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.

NAA15 ACACB GIT1 HMGCS1 DBT APP SF3B1 GRK2 CDC16 EIF4G2 XRN1 PKP1 VCPIP1 GABRA5

6.88e-0511391261436417873
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

NAA15 LIMD1 GIT1 TBC1D5 ANKRD26 INPP5F SYNJ2 PLEKHG3 XRN1 FNIP1 TSSK1B VCPIP1

7.25e-058611261236931259
Pubmed

Dynamic changes occur in patterns of endometrial EFNB2/EPHB4 expression during the period of spiral arterial modification in mice.

EPHB4 RAG2

7.78e-054126218463357
Pubmed

Variants in the genes DCTN2, DNAH10, LRIG3, and MYO1A are associated with intermediate Charcot-Marie-Tooth disease in a Norwegian family.

DNAH10 LRIG3

7.78e-054126226517670
Pubmed

GRK2 negatively regulates IGF-1R signaling pathway and cyclins' expression in HepG2 cells.

CCNA2 GRK2

7.78e-054126223460259
Pubmed

Panel-based NGS Reveals Novel Pathogenic Mutations in Autosomal Recessive Retinitis Pigmentosa.

RP1 USH2A

7.78e-054126226806561
Pubmed

Protein phosphatase 2A (B55α) prevents premature activation of forkhead transcription factor FoxM1 by antagonizing cyclin A/cyclin-dependent kinase-mediated phosphorylation.

CCNA2 CDK1

7.78e-054126221813648
Pubmed

Possible involvement of glial cell line-derived neurotrophic factor and its receptor, GFRalpha1, in survival and maturation of thymocytes.

RAG2 GFRA1

7.78e-054126212884298
Pubmed

Essential role of beta-adrenergic receptor kinase 1 in cardiac development and function.

GRK2 GRK3

7.78e-05412628917529
Pubmed

Overexpression of BUB1B, CCNA2, CDC20, and CDK1 in tumor tissues predicts poor survival in pancreatic ductal adenocarcinoma.

CCNA2 CDK1

7.78e-054126230765611
Pubmed

Interleukin-25 induces type 2 cytokine production in a steroid-resistant interleukin-17RB+ myeloid population that exacerbates asthmatic pathology.

RAG2 IL17RB

7.78e-054126222543263
Pubmed

Hierarchical organization of multi-site phosphorylation at the CXCR4 C terminus.

GRK2 GRK3

7.78e-054126223734232
Pubmed

Identification, tissue specific expression, and chromosomal localisation of several human dynein heavy chain genes.

DNAH10 DNAH6

7.78e-054126211175280
Pubmed

Amyloid-β oligomers induce synaptic damage via Tau-dependent microtubule severing by TTLL6 and spastin.

APP TTLL6

7.78e-054126224065130
Pubmed

Cyclin B and cyclin A confer different substrate recognition properties on CDK2.

CCNA2 CDK1

7.78e-054126217495531
Pubmed

Reduced expression of G protein-coupled receptor kinases in schizophrenia but not in schizoaffective disorder.

GRK2 GRK3

7.78e-054126221784156
Pubmed

NF-Y binds to both G1- and G2-specific cyclin promoters; a possible role in linking CDK2/Cyclin A to CDK1/Cyclin B.

CCNA2 CDK1

7.78e-054126221871181
Pubmed

The SAC domain-containing protein gene family in Arabidopsis.

INPP5F SYNJ2

7.78e-054126212805586
Pubmed

Phosphorylation of the type 1A angiotensin II receptor by G protein-coupled receptor kinases and protein kinase C.

GRK2 GRK3

7.78e-05412628662816
Pubmed

Distinct roles for the mammalian A-type cyclins during oogenesis.

CCNA2 CDK1

7.78e-054126216183859
Pubmed

An essential phosphorylation-site domain of human cdc25C interacts with both 14-3-3 and cyclins.

CCNA2 CDK1

1.29e-045126210864927
Pubmed

Metabolic regulator Fnip1 is crucial for iNKT lymphocyte development.

RAG2 FNIP1

1.29e-045126224785297
Pubmed

Cdc25M2 activation of cyclin-dependent kinases by dephosphorylation of threonine-14 and tyrosine-15.

CCNA2 CDK1

1.29e-04512628475101
Pubmed

Phosphorylation of threonine 61 by cyclin a/Cdk1 triggers degradation of stem-loop binding protein at the end of S phase.

CCNA2 CDK1

1.29e-045126218490441
Pubmed

Group IVA Cytosolic Phospholipase A2 Regulates the G2-to-M Transition by Modulating the Activity of Tumor Suppressor SIRT2.

CCNA2 SIRT2

1.29e-045126226303530
Pubmed

Cdk2 knockout mice are viable.

CCNA2 CDK1

1.29e-045126214561402
Pubmed

Hamartin and tuberin interaction with the G2/M cyclin-dependent kinase CDK1 and its regulatory cyclins A and B.

CCNA2 CDK1

1.29e-045126211444800
Pubmed

Imputation-based meta-analysis of severe malaria in three African populations.

ZNF804A OR51F1

1.29e-045126223717212
Pubmed

Phosphorylation of Cdc25B3 Ser169 regulates 14-3-3 binding to Ser151 and Cdc25B activity.

CCNA2 CDK1

1.29e-045126221558810
Pubmed

Rapamycin inhibition of interleukin-2-dependent p33cdk2 and p34cdc2 kinase activation in T lymphocytes.

CCNA2 CDK1

1.29e-04512628226784
Pubmed

Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation.

CCNA2 CDK1

1.29e-04512627969176
Pubmed

N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.

GPI NAA15 ACACB LIMD1 TBC1D5 ANKRD26 SIRT2 SF3B1 FEN1 EIF4G2 XRN1 VCPIP1

1.55e-049341261233916271
Pubmed

Interaction of LATS1 with SMAC links the MST2/Hippo pathway with apoptosis in an IAP-dependent manner.

IPPK DBT PPM1B SF3B1 PKP1 CPSF1

1.65e-04222126635941108
Pubmed

Alzheimer's disease risk variants show association with cerebrospinal fluid amyloid beta.

APP TF

1.93e-046126218813964
Pubmed

Destabilization of CARP mRNAs by aloe-emodin contributes to caspase-8-mediated p53-independent apoptosis of human carcinoma cells.

CCNA2 CDK1

1.93e-046126221308745
Pubmed

Polyubiquitylation of AMF requires cooperation between the gp78 and TRIM25 ubiquitin ligases.

GPI AMFR

1.93e-046126224810856
Pubmed

G2 delay induced by nitrogen mustard in human cells affects cyclin A/cdk2 and cyclin B1/cdc2-kinase complexes differently.

CCNA2 CDK1

1.93e-04612628463339
Pubmed

Reciprocal activation by cyclin-dependent kinases 2 and 7 is directed by substrate specificity determinants outside the T loop.

CCNA2 CDK1

1.93e-046126211113184
Pubmed

Exome sequencing of index patients with retinal dystrophies as a tool for molecular diagnosis.

RP1 USH2A

1.93e-046126223940504
Pubmed

USP18 (UBP43) Abrogates p21-Mediated Inhibition of HIV-1.

CCNA2 CDK1

1.93e-046126230068654
Pubmed

Identification of cellular proteins interacting with the retroviral restriction factor SAMHD1.

CCNA2 CDK1

1.93e-046126224623419
Pubmed

Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation.

RAG2 IL1RAP

1.93e-046126217908936
Pubmed

EBI2 guides serial movements of activated B cells and ligand activity is detectable in lymphoid and nonlymphoid tissues.

GPI CXCR5

1.93e-046126221844396
Pubmed

Myc stimulates cell cycle progression through the activation of Cdk1 and phosphorylation of p27.

CCNA2 CDK1

1.93e-046126231822694
Pubmed

Characterization of the in vitro reconstituted cyclin A or B1-dependent cdk2 and cdc2 kinase activities.

CCNA2 CDK1

1.93e-04612628397207
Pubmed

Function of the cytoplasmic tail of human calcitonin receptor-like receptor in complex with receptor activity-modifying protein 2.

GRK2 GRK3

1.93e-046126220074556
Pubmed

Cyclin A2-cyclin-dependent kinase 2 cooperates with the PLK1-SCFbeta-TrCP1-EMI1-anaphase-promoting complex/cyclosome axis to promote genome reduplication in the absence of mitosis.

CCNA2 CDK1

1.93e-046126219822658
Pubmed

Combinatorial depletions of G-protein coupled receptor kinases in immune cells identify pleiotropic and cell type-specific functions.

GRK2 GRK3

1.93e-046126236451830
Pubmed

A distinct cyclin A is expressed in germ cells in the mouse.

CCNA2 CDK1

1.93e-04612628565853
Pubmed

Identification and genetic monitoring of mouse inbred strains using biochemical polymorphisms.

GPI TF

1.93e-0461262926748
Pubmed

The human 18S U11/U12 snRNP contains a set of novel proteins not found in the U2-dependent spliceosome.

RNPC3 SF3B1 ZCRB1

2.56e-0434126315146077
GeneFamilyTransferrins

TF MELTF

6.85e-053872908
CoexpressionGSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_TREG_UP

POLR1A MED13L NSMF OTUD6B ANKIB1 MAPKBP1 ARHGAP45 FGD3

4.86e-062001238M4313
ToppCellPBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

MMS22L FASTKD1 PPM1B SLC25A40 WDR11 SYNJ2 PLEKHG3 IL1RAP

7.16e-0819012683f0c7d130f66faea778fe567604edf1b4cdf85b3
ToppCellPBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MMS22L FASTKD1 PPM1B SLC25A40 WDR11 SYNJ2 PLEKHG3 IL1RAP

7.76e-081921268c09dcc73ff9c3855a0f3d7bfa0d5c99c09a117f2
ToppCellControl-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class

LIMD1 C5AR2 MED13L B4GALT5 TMTC1 GRK3 ADGRE1 QKI

8.75e-081951268b4444b67a709e82b8e2ee510924c3152cb88b051
ToppCellLPS_anti-TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

MMS22L DNAH10 ANKMY1 DNAAF11 ADGB TTLL6 RP1 DNAH6

1.02e-07199126815f7814b7074170eee7ccacaa670b1d128fc68bb
ToppCellLPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DNAH10 DNAAF11 ADGB TTLL6 RP1 USH2A DNAH6

2.88e-0715412679ca71d440c4f87781e6525b8141e7d8d470b6a8e
ToppCellLPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DNAH10 DNAAF11 ADGB TTLL6 RP1 USH2A DNAH6

2.88e-07154126758072ce422d09f2de602580325eaac6c4ec6c136
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

ACACB LIMD1 ABHD18 CD109 SLC9A1 TADA2B MAPKBP1

1.18e-06190126763018acb7ad80415e861643162abdc2e55968ee4
ToppCellControl-Myeloid-ncMonocyte|Control / Disease state, Lineage and Cell class

LIMD1 C5AR2 MED13L B4GALT5 TMTC1 GRK3 ADGRE1

1.41e-061951267fcb05948e7480dc53f06f3fc9b9c3fc129874edd
ToppCellControl_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type

DNAH10 ANKMY1 DNAAF11 ADGB TTLL6 RP1 DNAH6

1.41e-06195126760067b5359174f0d1a8b5748bfc0690762e9e740
ToppCell3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DNAH10 ANKRD26 ADGB TTLL6 ZFHX2 RP1 DNAH6

1.51e-06197126774a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCellControl_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type

DNAH10 ANKMY1 TF ADGB TTLL6 PKP1 DNAH6

1.56e-061981267e6863238e022ecfb6a8e3f4b7661b376e92c5d8f
ToppCellControl_saline-Epithelial_airway-airway_epithelial|Control_saline / Treatment groups by lineage, cell group, cell type

DNAH10 ANKMY1 TF ADGB TTLL6 PKP1 DNAH6

1.56e-061981267e7aa42e5fbd42c68f50cda4a8f3aa464c862c007
ToppCellLPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type

FBXL13 DNAH10 ANKMY1 DNAAF11 ADGB RP1 DNAH6

1.56e-0619812676d90b541fde357fbb40f8f7d4e8628a48b679718
ToppCellLPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

DNAH10 ANKMY1 TF ADGB TTLL6 RP1 DNAH6

1.67e-062001267da12821e8a0657869ca0f75d351cce2d7605a505
ToppCellLPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

DNAH10 ANKMY1 TF ADGB TTLL6 RP1 DNAH6

1.67e-06200126772c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb
ToppCellLPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DNAH10 ANKMY1 ADGB TTLL6 RP1 DNAH6

4.07e-061481266d61123f0c811287843d066b932b4a9ff09c07c5b
ToppCellLPS-antiTNF-Epithelial_airway-Ciliated_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DNAH10 ANKMY1 ADGB TTLL6 RP1 DNAH6

4.07e-061481266c8e93b87212f55774223caa385859c566fa1981f
ToppCellfacs-Lung-EPCAM-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

B4GALT5 GRK2 GRK3 AP1G2 FGR ADGRE1

5.93e-061581266b0508a600994090c6aafd8d779437190a33ad821
ToppCellfacs-Lung-EPCAM-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

B4GALT5 GRK2 GRK3 AP1G2 FGR ADGRE1

5.93e-061581266a816cc095452308d06f87b77467e2a8c6361fd2a
ToppCellE16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DNAH10 DNAAF11 ADGB TTLL6 RP1 DNAH6

8.43e-061681266fa7c0303918cea04e3f4c4f3cb079be19004d214
ToppCellE16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DNAH10 DNAAF11 ADGB TTLL6 RP1 DNAH6

8.43e-0616812667edcab103c69e928d5c19a0d218ffb3ae32f9e70
ToppCell5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

FBXL13 DNAH10 DNAAF11 ADGB TTLL6 DNAH6

1.21e-0517912665e5f1cdf4aa66868d45b74ba91e20e848a3cbaff
ToppCell(6)_Endothelial-F_(Lymphatics)|World / Lung cell shreds - cell class (v4) and cell subclass (v4)

EPHB4 ADCY4 OXGR1 LAMA4 PGAP4 APP

1.41e-05184126603ea613e00b45c81b752c14505a0538d698f551e
ToppCellpdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

ACACB GAS2 SLC2A14 MED13L TF TRIM50

1.46e-0518512661d874608aa2062024323512f68889219471b2f00
ToppCellAdult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor

FBXL13 DNAH10 ADGB ZFHX2 RP1 DNAH6

1.46e-05185126630f4980dee6cd5959655f8d74049f3bfb5312611
ToppCell3'_v3-GI_small-bowel-Lymphocytic_NK-Cycling_NK|GI_small-bowel / Manually curated celltypes from each tissue

CCNA2 ADGB ARHGEF39 ZFHX2 CDK1 FGR

1.55e-051871266265c690c2921fd201361a0ec8bc4d2a996fbcaf4
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

EVI2B ZNF804A GRK3 FGR ADGRE1 ARHGAP45

1.60e-0518812664e27ada1bda88811b73376c8a6136cbfc83bfdb9
ToppCellChildren_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

EPHB4 ADCY4 OXGR1 LAMA4 APP TMTC1

1.60e-051881266aeecbc057dc823f8fcea8a98f18d213bacc7f4db
ToppCellPBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SLC2A14 GRK2 GRK3 FGR ADGRE1 ARHGAP45

1.75e-051911266c9f3bdb5c0a90268cab24a0fe4c3a8290fcedeb8
ToppCellPND07-Epithelial-Epithelial_Airway|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DNAH10 DNAAF11 ADGB TTLL6 PKP1 DNAH6

1.75e-051911266b55500eb416f4f339031acad16b2737e5b891d8e
ToppCellPBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

SLC2A14 GRK2 GRK3 FGR ADGRE1 ARHGAP45

1.80e-051921266b86476037ddf8904c1d8a6b3763af7242c031cf3
ToppCellIPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class

FBXL13 DNAH10 DNAAF11 ADGB RP1 DNAH6

1.85e-051931266ad58f5080e0ba65c845056ea6b79037b636e9c64
ToppCellControl-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class

LIMD1 C5AR2 MED13L B4GALT5 TMTC1 ADGRE1

1.85e-0519312663479c01aaae7afd7e02d00e0cb21951c0106a0fd
ToppCellPBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

GPI MMS22L DNAH10 B4GALT5 CCNA2 CDK1

1.85e-051931266ccab6a0c76f574ef7e1d6d5f1e620376daf21bbf
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ADCY4 CD109 TMTC1 SULT1B1 SYNJ2 IFI44L

1.85e-0519312666a623acd1adad9a78eddc32ffedb16352ad3fdfa
ToppCellPBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

GRK2 GRK3 IFI44L FGR ADGRE1 ARHGAP45

1.85e-0519312664fb020f11fd7aff06952bfeaabc79b2c7b8873f6
ToppCellnucseq-Immune-Immune_Myeloid-pMON-pMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

C5AR2 GRK2 GRK3 FGR ADGRE1 FGD3

1.91e-051941266e237384b02be460d44eeada3026a5691c66f6fc1
ToppCellnucseq-Immune-Immune_Myeloid-pMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

C5AR2 GRK2 GRK3 FGR ADGRE1 FGD3

1.91e-0519412660bc83ae79873a5e473e6e1e3111924cd003986a1
ToppCellPBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

GRK2 GRK3 IFI44L FGR ADGRE1 ARHGAP45

1.91e-051941266885355ebe98e974f841cc59dce3b5228c642c5d0
ToppCellmoderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

DNAH10 DNAAF11 ADGB DIAPH2 RP1 DNAH6

1.96e-0519512663486eae5fdb062a75a907b896c9d7b396d2aa195
ToppCellNS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

DNAH10 DNAAF11 ADGB DIAPH2 RP1 DNAH6

2.08e-05197126671fea4aa6ce96c7693fa94792d08770622873850
ToppCellcontrol-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

DNAH10 DNAAF11 ADGB DIAPH2 RP1 DNAH6

2.08e-051971266e453d085182364ca347cbcc9dc995c62c3353016
ToppCellControl-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class

SF3B1 GRK2 GRK3 EIF4G2 QKI ARHGAP45

2.08e-051971266eb7610c9496a95a5fd866e16abcbc39b83abe617
ToppCellcontrol-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

DNAH10 DNAAF11 ADGB DIAPH2 RP1 DNAH6

2.08e-051971266d4e963c1f82996371bf3d63578ee9fce8e00c5a8
ToppCellTracheal-NucSeq-Epithelial-Epi_airway_ciliated-Deuterosomal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DNAH10 DNAAF11 ADGB ZFHX2 RP1 DNAH6

2.14e-051981266f31790442ef142f1c0c49bf3daf2d0efb193d2c9
ToppCellcritical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

DNAH10 DNAAF11 ADGB DIAPH2 RP1 DNAH6

2.14e-051981266ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40
ToppCellsevere-Myeloid-Immature_Neutrophils_2|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

GPI MMS22L APP CCNA2 FEN1 CDK1

2.14e-051981266844f534551483c89ef789d1cfeb4680e54f794b2
ToppCellsevere-Myeloid-Immature_Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

GPI MMS22L APP CCNA2 FEN1 CDK1

2.14e-051981266e36303628af3139310c1d7a84d2919b7319bbda4
ToppCellLPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

DNAH10 ANKMY1 ADGB TTLL6 RP1 DNAH6

2.26e-05200126696701a4d57753f5ec0dd5c7550054bbcc946bc5f
ToppCellBrain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Unfolded_protein_responsible_cell|6m / Sample Type, Dataset, Time_group, and Cell type.

GALNT3 CDHR2 CBLC SLC5A1 MELTF SULT1B1

2.26e-05200126612078bc25be67180c0f4b37fef921cdcd1003576
ToppCellLPS_IL1RA-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

DNAH10 ANKMY1 ADGB TTLL6 RP1 DNAH6

2.26e-0520012664992dbf0514d674017315dbd20d91dfec0c608e9
ToppCellHippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Pvrl3|Hippocampus / BrainAtlas - Mouse McCarroll V32

GALNT3 MYO5B CD109 LOXHD1 NSMF

3.08e-0512712659bc55cb9f4bddb274930784d12a83b9dceb35cb7
ToppCellE16.5-samps-Myeloid-Macrophage|E16.5-samps / Age Group, Lineage, Cell class and subclass

CFHR2 DNAAF11 RP1 ADGRE1 ARHGAP45

6.38e-051481265cd5f697d8c2f272be1f3f52a05446749278431c5
ToppCellE16.5-samps-Myeloid-Macrophage-CD163+_Macrophage|E16.5-samps / Age Group, Lineage, Cell class and subclass

CFHR2 DNAAF11 RP1 ADGRE1 ARHGAP45

6.38e-05148126556e146980a71b5ca655118ae13310c5949220d4a
ToppCellControl-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DNAH10 ANKMY1 ADGB TTLL6 DNAH6

7.70e-0515412654e3bc24043144143842627cacf6f90dda2228910
ToppCellControl-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DNAH10 ANKMY1 ADGB TTLL6 DNAH6

7.70e-0515412657556a4b2b062da5ae7ec2bbb66e745e7662db628
ToppCellLPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DNAH10 ADGB TTLL6 RP1 DNAH6

7.94e-0515512655f1e2195a6b831e1b636f5cc3a282ca423721822
ToppCellLPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DNAH10 ADGB TTLL6 RP1 DNAH6

7.94e-0515512650944429459f642a1bcc56edc1ec28aaecde3e2dc
ToppCelldroplet-Liver-LIVER_NPC-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FBXL13 EVI2B PPEF2 GRM8 FGR

9.22e-051601265e9e52532131cdc3fb01e81cfc046e3f670cc8e75
ToppCellfacs-Lung-ENDOMUCIN-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

B4GALT5 GRK3 FGR ADGRE1 ARHGAP45

9.22e-0516012652020b6defbaf5b5db12af37f0103ac028a8ca76e
ToppCellfacs-Lung-ENDOMUCIN-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

B4GALT5 GRK3 FGR ADGRE1 ARHGAP45

9.22e-051601265af7cf0dc5fe7c02f7d6c436f6dde766c79ff0eae
ToppCellfacs-Lung-EPCAM-3m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ABHD18 CCNA2 ARHGEF39 CDK1 FGD3

9.50e-051611265a7e74bc80ac11250e353e5614b19c05793fc2e95
ToppCellfacs-Lung-Endomucin-24m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GAS2 CD109 CBLC ARHGEF39 CDK1

9.78e-051621265497ae9f86a5e7946d0fde932b35719a382a6b691
ToppCellfacs-Lung-Endomucin-24m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GAS2 CD109 CBLC ARHGEF39 CDK1

9.78e-0516212657b2949eba2b4aea239d96ed82aafab13b07624eb
ToppCelldroplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GALNT3 DNAH10 GRK3 FGR ADGRE1

1.01e-0416312658dc0128eeede933537e3bcc5d6ec0322711552f3
ToppCelldroplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GALNT3 DNAH10 GRK3 FGR ADGRE1

1.01e-041631265fd243ca223079033be480a24817a399f281fa4d4
ToppCellPND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

GAS2 LOXHD1 FEN1 CDK1 IL17RB

1.04e-0416412655621c2e3fae84d5a2e4f1595e454bcb3a2b3f93c
ToppCellfacs-MAT-Fat-18m-Myeloid|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

C5AR2 EVI2B GRK3 FGR ADGRE1

1.10e-0416612659116be2805c34881debb999d8417e43832fcf2f2
ToppCellPND07-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

C5AR2 CCNA2 ARHGEF39 CDK1 ADGRE1

1.10e-041661265bb8135119dc37fdbba476599a56d368f422688dc
ToppCellfacs-MAT-Fat-18m-Myeloid-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

C5AR2 EVI2B GRK3 FGR ADGRE1

1.10e-0416612655c2667da79935f3d4b1edbfe7a10e7dbc2fa3ad0
ToppCell5'-Adult-SmallIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LIMD1 MELTF DIAPH2 ZFHX2 IL17RB

1.16e-0416812658072d0496b7b730c4601009eaa69ec5366d26d73
ToppCelldroplet-Marrow-nan-24m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADCY4 IP6K3 TMEM127 GRK3 ADGRE1

1.16e-041681265e979a4fbeb9f21048b47d69e6da75c57650697f2
ToppCellfacs-Lung-24m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

B4GALT5 GRK2 GRK3 FGR ADGRE1

1.16e-041681265c0aef5947b1d7e2c81a7481c509feda1687fcd7f
ToppCellfacs-Lung-24m-Hematologic-myeloid-non-classical_monocyte|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

B4GALT5 GRK2 GRK3 FGR ADGRE1

1.16e-041681265c861f80aa12caf54a94d93e38539ff41dc5227a6
ToppCellCOVID-19_Mild-Classical_Monocyte-cMono_1|Classical_Monocyte / Disease condition and Cell class

ARID5A GRK2 GRK3 GUCY1A2 ARHGAP45

1.16e-041681265d50078614f7af74dc2aa4081c1708a5156ac51cf
ToppCell5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DNAH10 DNAAF11 ADGB RP1 DNAH6

1.19e-041691265fba841664939c771881ba97f14ef1df6635c04ff
ToppCell3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DNAH10 DNAAF11 ADGB RP1 DNAH6

1.19e-04169126514aadc2d1bf66eb47dac33b4d61ddb3c942caa4f
ToppCell5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CDHR2 TMEM63C CBLC RNF43 TTLL6

1.23e-041701265985c2d5962100fab0d95bee39f382ccbe799331e
ToppCellfacs-Diaphragm-Limb_Muscle-18m-Myeloid|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

EVI2B CCNA2 FEN1 CDK1 FGR

1.23e-041701265d582087a983fe20d811d92f0de0458f3cfd71d2b
ToppCellfacs-Diaphragm-Limb_Muscle-18m-Myeloid-macrophage|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

EVI2B CCNA2 FEN1 CDK1 FGR

1.23e-041701265dfbe7ba11b867a4e10fa915f282a2e5cb2f5fb8c
ToppCellcontrol-Myeloid-Monocyte-derived_Macrophage|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

CD109 SLC2A14 ARID5A FGR ARHGAP45

1.26e-041711265e828b684744a4fdf6b63ec033c4f000b39ca0d51
ToppCellfacs-Diaphragm-Limb_Muscle-18m-Myeloid-new-cluster|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

EVI2B CCNA2 FEN1 CDK1 FGR

1.26e-041711265d0d92eb5152410c3b4dd4a3f1dc3cca0e18a85fd
ToppCellfacs-Lung-18m-Hematologic-myeloid|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

EVI2B GRK3 FGR ADGRE1 ARHGAP45

1.26e-0417112654ad28ecfde3d529a09b80be908c446bd5274518e
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Neutrophil|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

EVI2B SULT1B1 GRK2 FGR IL1RAP

1.26e-041711265ef9397cec7f5c217d34583f26270af7ed7fbcebf
ToppCellPND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DNAAF11 CCNA2 ARHGEF39 CDK1 IL17RB

1.30e-041721265ba36581ae339191a12a6d3ead39eaf69d78be10e
ToppCelldroplet-Pancreas-Exocrine-21m-Epithelial-pancreatic_ductal_cel|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GALNT3 CCNA2 TTLL6 ARHGEF39 PKP1

1.30e-041721265c0bda7153e02bee7d0326138cc684151c404c2a1
ToppCellfacs-Lung-ENDOMUCIN-18m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

EVI2B GRK2 FGR ADGRE1 ARHGAP45

1.30e-0417212650457ccc18697aaec44b7c30ae157aae8f48d8785
ToppCelldroplet-Lung-21m-Epithelial-airway_epithelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

GFRA1 ADGB TTLL6 RP1 DNAH6

1.33e-041731265a809be2630d2b91b53b82b5e2bb99e05524597c1
ToppCellfacs-Trachea-nan-24m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DNAH10 DNAAF11 ADGB TTLL6 RP1

1.33e-04173126527ae126c720f20d1fe116abbcd358e4cff8baf6b
ToppCell(00)_Basal-(1)_24hpi|(00)_Basal / shred by cell type and Timepoint

MMS22L CD109 B4GALT5 FEN1 CDK1

1.33e-041731265a8e62e7d8baf6af691acd5c50deedbadc119ceba
ToppCell3'-GW_trimst-1.5-LargeIntestine-Epithelial-epithelial_progenitor_cell-TA|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GALNT3 CBLC CCNA2 ARHGEF39 DNAH6

1.33e-041731265021457c7bdb55de7351e43322d360e8fd7061658
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic-Neutrophil|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

C5AR2 EVI2B SULT1B1 FGR GABRA5

1.33e-041731265dfa56753319c92ae5b337793c4d6d5f70afce546
ToppCellPND07-28-samps-Epithelial-Epithelial-non_alveolar-Ciliated_cell_of_lung_parenchyma|PND07-28-samps / Age Group, Lineage, Cell class and subclass

DNAH10 DNAAF11 TTLL6 RP1 DNAH6

1.37e-041741265f41d05a3703d7092bd3c4a97c15ae13069aaa4ad
ToppCellNS-control-d_0-4-Myeloid-Monocyte-derived_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

CD109 SLC2A14 ARID5A FGR ARHGAP45

1.37e-041741265758984730cd1c3ccf6866a3a8f03d6e002f3edb6
ToppCell3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CCNA2 ZNF530 ARHGEF39 PKP1 CDK1

1.37e-0417412652a96a4fd7d9ef05213b26103c689cf3a26968713
ToppCelldroplet-Pancreas-Exocrine-21m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GALNT3 TTLL6 ARHGEF39 PKP1 RP1

1.37e-041741265a0ccda8fd6f55251cdeff24cf66e72e4a31d2104
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Enterocyte|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYO5B CDHR2 TMEM127 SULT1B1 ANKIB1

1.37e-0417412652fbdb62e269acf4447b171700a615e878dde7f9f
ToppCellwk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

MYO5B OXGR1 CBLC COG8 PKP1

1.37e-0417412659e5fae9ecc7c0111fc8a252e72b89dc89c0d3a7c
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYO5B CDHR2 TMEM127 SULT1B1 ANKIB1

1.37e-0417412657c52b5d8f1e65e5208c952be341fa155ed0e6e76
ToppCellPND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

FBXL13 CCNA2 GUCY1A2 ARHGEF39 CDK1

1.37e-0417412656c36d607c48267a75ab4da6fb2fe3f931d1b3b52
ComputationalGenes in the cancer module 205.

ADCY4 ACTR5 CDHR2 CD109 INPP5F TF CCNA2 WDR11 SYNJ2 DNAH6

9.21e-053058110MODULE_205
DrugDyclonine hydrochloride [536-43-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A

EPHB4 ACTR5 HMGCS1 APP GRK2 SLC25A40 PLEKHG3 ZFHX2 ARHGAP45

1.49e-0619612697423_UP
DrugAcetohexamide [968-81-0]; Down 200; 12.4uM; HL60; HT_HG-U133A

IPPK ACACB ACTR5 SMG5 DBT APP SYNJ2 IFI44L QKI

1.56e-0619712691870_DN
DrugCephalothin sodium salt [58-71-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A

ACACB C5AR2 RXYLT1 DBT SULT1B1 GRK2 MAPKBP1 QKI VCPIP1

1.69e-0619912696079_DN
Drugprostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A

AMFR ACACB LAMA4 DNAAF11 GRK2 PKP1 IFI44L QKI

8.37e-0618312686547_UP
DrugEtoposide [33419-42-0]; Down 200; 6.8uM; MCF7; HT_HG-U133A

APP GRM8 CCNA2 GRK2 GRK3 CDK1 QKI IL17RB

9.06e-0618512683241_DN
DrugPerphenazine [58-39-9]; Down 200; 10uM; HL60; HG-U133A

GALNT3 APP TMEM127 URB1 SLC9A1 GRK3 SYNJ2 IL1RAP

1.43e-0519712682040_DN
DrugRapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A

AMFR SMG5 ARID5A METTL1 SLC9A1 NSMF GRK2 QKI

1.43e-0519712681183_DN
DrugAcenocoumarol [152-72-7]; Up 200; 11.4uM; HL60; HG-U133A

SMG5 MED13L APP TMEM127 ARID5A GRK2 PLEKHG3 MAPKBP1

1.43e-0519712681394_UP
DrugFluphenazine dihydrochloride [146-56-5]; Down 200; 7.8uM; PC3; HT_HG-U133A

EPHB4 AMFR GIT1 ABHD18 DBT APP PKP1 ARHGAP45

1.48e-0519812685880_DN
DrugPHA-00851261E [724719-49-7]; Up 200; 10uM; PC3; HT_HG-U133A

RAG2 CBLC PGAP4 DBT ARID5A ADGB PLEKHG3 GABRA5

1.60e-0520012683773_UP
DrugAC1O5WLA

CCNA2 GRK2 GRK3 CDK1

2.19e-05301264CID006442113
Drugmorphine hydrochloride

GPI ADCY4 C5AR2 DBH GRM8 GFRA1 CXCR5 GRK2 GRK3 ZCRB1 GABRA5

7.64e-0548112611CID000004253
DrugAmethopterin (R,S) [59-05-2]; Down 200; 8.8uM; MCF7; HT_HG-U133A

HMGCS1 APP CCNA2 PLEKHG3 DIAPH2 CDK1 QKI

8.93e-0518912673214_DN
DrugAcetohexamide [968-81-0]; Up 200; 12.4uM; PC3; HT_HG-U133A

ANKRD26 DBT APP RNF43 URB1 SULT1B1 IFI44L

9.85e-0519212671829_UP
Drugradicicol; Up 200; 0.1uM; HL60; HG-U133A

ACACB GIT1 APP SLC9A1 SLC25A40 SYNJ2 CEP57

1.02e-041931267544_UP
DrugCyanocobalamin [68-19-9]; Down 200; 3uM; PC3; HT_HG-U133A

LIMD1 TBC1D5 SMG5 DBT PLEKHG3 IFI44L QKI

1.05e-0419412674572_DN
DrugChlorzoxazone [95-25-0]; Up 200; 23.6uM; PC3; HT_HG-U133A

EPHB4 ACACB GRM8 GRK3 PKP1 ZFHX2 IFI44L

1.05e-0419412672100_UP
DrugFluorometholone [426-13-1]; Up 200; 10.6uM; MCF7; HT_HG-U133A

LAMA4 SMG5 APP GRK2 SYNJ2 QKI ARHGAP45

1.09e-0419512676247_UP
DrugMifepristone [84371-65-3]; Down 200; 9.4uM; HL60; HG-U133A

NAA15 TBC1D5 MED13L ARID5A SLC9A1 FEN1 MAPKBP1

1.12e-0419612671569_DN
DrugFlunarizine dihydrochloride [30484-77-6]; Up 200; 8.4uM; PC3; HT_HG-U133A

LIMD1 DBT ARID5A SIRT2 GRK2 CDC16 QKI

1.12e-0419612677252_UP
DrugTetracycline hydrochloride [64-75-5]; Down 200; 8.4uM; PC3; HT_HG-U133A

AMFR GIT1 ANKRD26 HMGCS1 DNAAF11 GRK3 ZFHX2

1.12e-0419612675757_DN
DrugMinoxidil [38304-91-5]; Down 200; 19.2uM; HL60; HG-U133A

GIT1 ABHD18 HMGCS1 APP SIRT2 QKI CEP57

1.12e-0419612671996_DN
DrugRacecadotril [81110-73-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A

AMFR ANKRD26 SLC9A1 GRK3 SYNJ2 PLEKHG3 CPSF1

1.16e-0419712676231_DN
DrugTrazodone hydrochloride [25332-39-2]; Down 200; 9.8uM; HL60; HT_HG-U133A

EPHB4 AMFR ANKMY1 APP URB1 PKP1 QKI

1.16e-0419712672379_DN
DrugNifenazone [2139-47-1]; Up 200; 13uM; PC3; HT_HG-U133A

GIT1 PGAP4 APP ARID5A URB1 GRK2 SLC25A40

1.16e-0419712672122_UP
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A

ANKMY1 SMG5 ZNF804A URB1 PLEKHG3 FGR ARHGAP45

1.16e-0419712672375_DN
DrugSulfamonomethoxine [1220-83-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A

AMFR C5AR2 HMGCS1 DBT SYNJ2 DIAPH2 AP1G2

1.16e-0419712673484_DN
DrugLansoprazole [103577-45-3]; Down 200; 10.8uM; MCF7; HT_HG-U133A

LIMD1 GIT1 RNF43 SIRT2 GRK2 IL1RAP QKI

1.16e-0419712673529_DN
DrugPheniramine maleate [132-20-7]; Down 200; 11.2uM; HL60; HG-U133A

GIT1 ABHD18 SMG5 DBT MED13L APP GRK2

1.16e-0419712671992_DN
DrugGlycopyrrolate [596-51-0]; Down 200; 10uM; HL60; HT_HG-U133A

EPHB4 AMFR ANKRD26 CILK1 GRK2 SYNJ2 MAPKBP1

1.16e-0419712672565_DN
DrugCP-944629 [668990-94-1]; Up 200; 10uM; MCF7; HT_HG-U133A

LIMD1 TBC1D5 ANKRD26 HMGCS1 GRK2 AP1G2 ARHGAP45

1.19e-0419812677544_UP
DrugCP-863187 [668981-07-5]; Down 200; 10uM; MCF7; HT_HG-U133A

RNF43 SYNJ2 DIAPH2 ZFHX2 IL1RAP QKI VCPIP1

1.19e-0419812677508_DN
Drugcarbamazepine; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA

ANKMY1 DBT RNF43 SIRT2 SYNJ2 QKI ARHGAP45

1.19e-041981267919_DN
DrugCefixime [79350-37-1]; Down 200; 8.8uM; PC3; HT_HG-U133A

LIMD1 GIT1 TBC1D5 RXYLT1 GRK2 SYNJ2 QKI

1.19e-0419812674567_DN
DrugAmiloride hydrochloride dihydrate [17440-83-4]; Down 200; 13.2uM; HL60; HG-U133A

GIT1 MED13L APP TMEM127 PPM1B SLC25A40 MAPKBP1

1.19e-0419812671970_DN
DrugIsoxicam [34552-84-6]; Down 200; 12uM; HL60; HT_HG-U133A

IPPK ACTR5 GRK2 SYNJ2 DIAPH2 IFI44L IL1RAP

1.19e-0419812671862_DN
DrugTriamcinolone [124-94-7]; Down 200; 10.2uM; MCF7; HT_HG-U133A

IPPK ACTR5 CILK1 SMG5 TMEM127 GRK3 DIAPH2

1.23e-0419912677192_DN
DrugIproniazide phosphate [305-33-9]; Down 200; 14.4uM; HL60; HG-U133A

GIT1 SMG5 TMEM127 PPM1B SLC9A1 GRK3 CPSF1

1.23e-0419912671442_DN
DrugGallamine triethiodide [65-29-2]; Up 200; 4.4uM; HL60; HG-U133A

EPHB4 ACACB GIT1 SMG5 GRM8 PLEKHG3 CEP57

1.23e-0419912671375_UP
DrugSulfabenzamide [127-71-9]; Up 200; 14.4uM; PC3; HT_HG-U133A

EPHB4 LAMA4 GRM8 RNF43 SLC5A1 CPSF1 IL17RB

1.23e-0419912676634_UP
DrugPiretanide [55837-27-9]; Down 200; 11uM; PC3; HT_HG-U133A

CDHR2 GAS2 ANKMY1 SMG5 DNAAF11 GRK3 PKP1

1.23e-0419912674490_DN
DrugLoxapine succinate [27833-64-3]; Up 200; 9uM; HL60; HG-U133A

GIT1 CDHR2 LAMA4 HMGCS1 MED13L APP SULT1B1

1.27e-0420012672016_UP
DrugBisoprolol fumarate; Up 200; 9uM; MCF7; HT_HG-U133A

RAG2 LAMA4 GRM8 ARID5A MELTF EIF4G2 DIAPH2

1.27e-0420012672642_UP
DiseaseDrug-induced paranoid state

DBH CDK1

5.07e-0531222C1306067
Diseaseattention deficit hyperactivity disorder (is_implicated_in)

GIT1 DBH GRM8

7.47e-05201223DOID:1094 (is_implicated_in)
DiseaseREM sleep behavior disorder

TMEM175 INPP5F

2.52e-0461222EFO_0007462
Diseaseobesity (implicated_via_orthology)

DNAH10 TBC1D5 MC3R ANKRD26 MED13L ZFHX2

2.79e-042151226DOID:9970 (implicated_via_orthology)
Diseasechronic mucus hypersecretion

TBC1D5 USH2A

3.51e-0471222EFO_0005673
Diseasehypertension (biomarker_via_orthology)

SLC2A14 DBH APP GRK2 GRK3 EIF4G2

3.73e-042271226DOID:10763 (biomarker_via_orthology)
Diseasecomplement factor H measurement

GPI CFHR2 QKI

6.55e-04411223EFO_0008097
Diseasecolorectal cancer, endometrial neoplasm

GALNT3 TMTC1 GUCY1A2

7.04e-04421223EFO_0004230, MONDO_0005575
DiseaseMemory Loss

GIT1 APP GABRA5

7.54e-04431223C0751295
DiseaseAge-Related Memory Disorders

GIT1 APP GABRA5

7.54e-04431223C0751292
DiseaseMemory Disorder, Spatial

GIT1 APP GABRA5

7.54e-04431223C0751294
DiseaseMemory Disorder, Semantic

GIT1 APP GABRA5

7.54e-04431223C0751293
DiseaseMemory Disorders

GIT1 APP GABRA5

7.54e-04431223C0025261
DiseaseMemory impairment

GIT1 APP GABRA5

8.07e-04441223C0233794
Diseasepolybrominated biphenyl measurement, gestational serum measurement, fetal genotype effect measurement, polybrominated diphenyl ether measurement

TBC1D5 LOXHD1

9.10e-04111222EFO_0007959, EFO_0007961, EFO_0007962, EFO_0007964
Diseaseidiopathic scoliosis (implicated_via_orthology)

DNAH10 PPP2R3B

1.96e-03161222DOID:0060250 (implicated_via_orthology)
DiseasePheochromocytoma, Extra-Adrenal

DBH TMEM127

1.96e-03161222C1257877
Diseasemetabolically healthy obesity

CXCR5 QKI

2.48e-03181222EFO_0009382
DiseaseTourette syndrome, schizophrenia

DNAH10 TBC1D5

2.48e-03181222EFO_0004895, MONDO_0005090
Diseaserenovascular hypertension (biomarker_via_orthology)

SLC9A1 EIF4G2

2.77e-03191222DOID:1591 (biomarker_via_orthology)
DiseasePheochromocytoma

DBH TMEM127

2.77e-03191222C0031511
DiseaseSchizophrenia

MYO5B GRM8 ZNF804A TF GFRA1 CCNA2 ZNF530 WDR11 QKI GABRA5

3.71e-0388312210C0036341
DiseaseAttention Deficit Disorder

GIT1 GRM8

3.71e-03221222C0041671
DiseaseMinimal Brain Dysfunction

GIT1 GRM8

3.71e-03221222C1321905
Diseaseportal hypertension (biomarker_via_orthology)

DBH GRK2

3.71e-03221222DOID:10762 (biomarker_via_orthology)

Protein segments in the cluster

PeptideGeneStartEntry
AYIMKELLSCSHPFS

GRK3

111

P35626
FYCKGTHGIMSPLAK

ARID5A

246

Q03989
GLAHCCLNPMLYTFA

CXCR5

311

P32302
MHAELHALFPGGKYC

CBLC

131

Q9ULV8
KSTNLHDYGMLLPCG

APP

161

P05067
HDYGMLLPCGIDKFR

APP

166

P05067
CKAVKGHMPLFNSYG

ADGB

181

Q8N7X0
CKILDGHFVSPMAHY

ABHD18

66

Q0P651
GYPAHFGQMECLKLI

AP1G2

61

O75843
HYRLCLGDMPFVAGK

CEP57

281

Q86XR8
NTPLHYAAASGMKAC

ANKIB1

146

Q9P2G1
FLCGNVAGVYHKALM

ADCY4

181

Q8NFM4
YQMLAFVHKLPCRDD

GIT1

111

Q9Y2X7
FYHNKPKNSMCSGLI

ACTR5

171

Q9H9F9
EDCELPHSSYKNFML

ANKRD26

696

Q9UPS8
IVLHCSGMDPDFKYR

DIAPH2

456

O60879
YGCGQMPRHFATKLD

B4GALT5

246

O43286
TFACKALYPMAQCHL

ARHGEF39

271

Q8N4T4
SYIMKELLACSHPFS

GRK2

111

P25098
NDFGFMIFHSPYCKL

HMGCS1

256

Q01581
TELNKPAMIYCSHGD

RAG2

436

P55895
KFVHLLMSPGCNYLV

PPP2R3B

216

Q9Y5P8
KLMSSLPNFCGIFNH

QKI

26

Q96PU8
CPLDLYSGNKQRMHF

IPPK

181

Q9H8X2
TAVPCANHKMHLYLG

ACACB

1511

O00763
TMSAALKIPHFGYCD

DBT

266

P11182
PVHFQMLCESSKLYD

ARHGAP45

521

Q92619
LSAVYEMCRLGQHKP

MED13L

1441

Q71F56
DMILQALGKSYHPGC

LIMD1

546

Q9UGP4
QGACMALLSLHLFYK

EPHB4

181

P54760
FMCHGSLLDFLKNPE

FGR

336

P09769
SYSHNEGPGMKNLCL

LRIG3

1001

Q6UXM1
SCFNSPMKLPVHKLY

IL1RAP

136

Q9NPH3
LYPSHEKLLNDGFSM

MMS22L

641

Q6ZRQ5
HILKGCMPDRYQFNS

IFI44L

281

Q53G44
NFTSPGCLDHIMKYK

IL17RB

156

Q9NRM6
TFNFPDMLSLGHLCK

LOXHD1

1731

Q8IVV2
KQAHPPTGLEFSMYC

CPSF1

6

Q10570
VPFGLLYLCMKHLTD

TMEM63C

621

Q9P1W3
LLKPLYFCRMNALSH

OR51F1

171

A6NGY5
MDPKYFILILFCGHL

EVI2B

1

P34910
MFCDFPKINHGILYD

CFHR2

21

P36980
HSFRAMCQNGKLVYP

CFHR2

251

P36980
HLDSLLGQCMYFGLS

COG8

341

Q96MW5
HGCFAQMDRSLALPK

EVC2

856

Q86UK5
YLHLDKGSCSSDPML

LMLN2

466

A0A1B0GTW7
KMLIFCQGGPGHLYL

NSMF

406

Q6X4W1
PMDAHACPLKFGSYA

GABRA5

181

P31644
FYQLIHQGTKMIPCD

GPI

391

P06744
HLFLFNSMILYCVPK

FGD3

391

Q5JSP0
CHKGFGKDMALYSLL

PGAP4

356

Q9BRR3
HFFCDLMPLLKLSGS

OR1I1

176

O60431
SLLLKNHYNGMSFVC

SLC2A14

376

Q8TDB8
LHNMHKDLCPGYIGL

GRM8

416

O00222
VHCYNSNFPKGMLLR

EIF4G2

836

P78344
SQYTHPCVLDLKMGT

IP6K3

206

Q96PC2
ANCHKLFPYALAFMP

NAA15

826

Q9BXJ9
GIICLDSKLHTPMYF

OR2A2

46

Q6IF42
FGNCTDENIPLKMHY

OXGR1

21

Q96P68
QLEIKQIPSDGHCMY

OTUD6B

146

Q8N6M0
AYFTAAQLMKGCHLP

CDC16

356

Q13042
PLYCSMNSKHLNGTI

CD109

236

Q6YHK3
QLELKACDLGGMYHN

CDHR2

201

Q9BYE9
GLFEQHKLIYSFMLC

DNAH6

3361

Q9C0G6
CKHLLSLMGIPYLDA

FEN1

141

P39748
LAHSCLNPMLFLYFG

C5AR2

281

Q9P296
DKVPAKHSYGMLFCS

GFRA1

201

P56159
LLYNPFLKMCLSANG

GALNT3

596

Q14435
FLKMCLSANGEHPSL

GALNT3

601

Q14435
LMRHIPVDSYGKCLQ

FUT11

231

Q495W5
LQLYKHNLSPNFCVM

FNIP1

1091

Q8TF40
VLKALYSFAPISMHC

DBH

551

P09172
CLADQHLYFSPLMGK

FASTKD1

161

Q53R41
SMCFLLHYPAQSFKP

ANKMY1

331

Q9P2S6
PNLSHIYMADCKGIT

FBXL13

426

Q8NEE6
KELFLMGNPCASFDH

DNAAF11

116

Q86X45
NGNLHSPMYFFLCSL

MC3R

66

P41968
LYHSVAGCKMPSAEQ

MAPKBP1

1436

O60336
GYTLESLKPCLMDLH

CCNA2

381

P20248
KMLALSRQHGCLPYA

DHX37

786

Q8IY37
ALHAVAKSFLGYNPM

DNAH10

2966

Q8IVF4
VHILTGFAKPMDIYC

INPP5F

946

Q9Y2H2
MLHDERPYLCNFLGT

RXYLT1

261

Q9Y2B1
MQFLIRSHECKPEGY

PPEF2

481

O14830
HLPLDINFRGCMKGF

LAMA4

1191

Q16363
PLELKCNYFNMPHGS

RP1

1811

P56715
LCKELPEGTLMLHYF

GUCY1A2

226

P33402
MNHSPLKTALAYECF

PKP1

1

Q13835
GYLLKHDPCRMLQIS

GAS2

261

O43903
IKFVMLALNAFPSCH

TAS2R42

266

Q7RTR8
GCLKDVHFMKNYNPS

USH2A

1671

O75445
HYSNEINKACMPFGL

POLR1A

871

O95602
HEYLHAMKGLLCDPN

MELTF

346

P08582
ELCVKLMFLHPVDYG

SMG5

61

Q9UPR3
KLCFPMGRNVFSHDY

SYNJ2

706

O15056
VSMYIHGNLGKACIP

TADA2B

111

Q86TJ2
PKGKCFVYSNGLMDH

SLC25A40

51

Q8TBP6
HFVYKGNIPCSSLML

PLEKHG3

336

A1L390
KLMQSHPLYLCNASD

RNF43

81

Q68DV7
GQFKPTICHYFMRLL

SIRT2

141

Q8IXJ6
GVMISPKHIYFINCG

PPM1B

136

O75688
LMDLCCSLKHGINFY

URB1

311

O60287
DLKLVHGYPMTCAFA

SULT1B1

11

O43704
NKMGCAIIAGFLHYL

ADGRE1

661

Q14246
DSMQAARKLPCGHLF

AMFR

346

Q9UKV5
ISGKMALNHPYFNDL

CDK1

276

P06493
FFHRDLKPENLLCMG

CILK1

121

Q9UPZ9
HVLMFAKLALYPCAS

TMEM175

416

Q9BSA9
IPMGLLYNKINHCRF

TF

481

P02787
PSMGYCILFVHGLSK

TMTC1

416

Q8IUR5
LCRLGFSKPQAFMDH

ZFHX2

241

Q9C0A1
NHGLTFPLNSCLKYM

RNPC3

146

Q96LT9
MLQYCLQGLFHPARK

SF3B1

1246

O75533
ASKNLLPACYQHLMT

XRN1

521

Q8IZH2
GYLLDKKHFPMCDLF

SLC9A1

466

P19634
YQKINHFPGMSEICR

TTLL6

111

Q8N841
HCKLLSPILARYGMD

VCPIP1

126

Q96JH7
LTGECKDLIYHMLQP

TSSK1B

241

Q9BXA7
GESGHLSYACPKNML

ZCRB1

111

Q8TBF4
MIELHASPCGQKLYL

ZNF530

106

Q6P9A1
QGLSLMAPHCQYSKE

ZNF782

146

Q6ZMW2
QTCLGLLMHYPFIGD

TBC1D5

386

Q92609
KHAECIYLGHFSDPM

THBS2

661

P35442
DCLQLAYLPSKRNHM

WDR11

246

Q9BZH6
YDLFCGLEQHGAPKM

SLC5A1

606

P13866
EVFKEPLMLQCGHSY

TRIM50

21

Q86XT4
VLGYVHPDLLKDFCM

TMEM127

71

O75204
CLRSNAMKHLPNFFY

METTL1

136

Q9UBP6
CHYELAEALPQGKMN

ZNF804A

971

Q7Z570
LLHCLKQYSGDEGFM

MYO5B

1556

Q9ULV0